Adult Vaccines Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Vaccines are products that guard people against dangerous and potentially life-threatening diseases. Most vaccines are given by injection, but some are given orally or nasally. All adults need seasonal flu (influenza) vaccine every year. The flu vaccine is very crucial for people with chronic health conditions, pregnant women, and older adults.

MARKET DYNAMICS

The adult vaccines market is anticipated to grow in the forecast, owing to rising prevalence of infectious diseases in the adult population with rising awareness among the population regarding the advantages of vaccination. In addition, increasing investment in R&D by governmental bodies for the development of novel drugs and vaccine is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Adult Vaccines Market Analysis to 2031" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in adult vaccines market with detailed market segmentation by type, by disease, by technology and geography. The in adult vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in adult vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The in adult vaccines market is segmented on the basis of type, by disease and technology. Based on type the market is segmented as preventive vaccine and therapeutic vaccine. On the basis of disease the market is categorized as influenza, meningococcal, zoster shingles, pneumococcal, diphtheria, tetanus, pertussis (DTP) and hepatitis, measles, mumps, rubella and varicella (MMRV). Also, based on technology, the market is segmented as, non-live attenuated vaccines, inactivated Viral/Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines and Conjugate Vaccines.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in Adult Vaccines Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The adult vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting adult vaccines market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the adult vaccines market in these regions.

Adult Vaccines Market Report Analysis

Adult Vaccines Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• AstraZeneca
• Bharat Biotech
• Dynavax Technologies Corporation
• GlaxoSmithKline
• Johnson and Johnson
• Merck and Co
• Novartis
• Pfizer
• Sanofi Pasteur

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Type

• Preventive Vaccine
• Therapeutic Vaccine

By Disease

• Influenza
• Meningococcal
• Zoster Shingles
• Pneumococcal
• Diphtheria
• Tetanus
• Pertussis
• Hepatitis
• Measles
• Mumps
• Rubella and Varicella

By Technology

• Non-Live Attenuated Vaccines
• Inactivated Viral/Bacterial Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Conjugate Vaccines

MARKET PLAYERS

The report covers key developments in the in Adult Vaccines Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in Adult Vaccines Market are anticipated to have lucrative growth opportunities in the future with the rising demand for in Adult Vaccines Market in the global market. Below mentioned is the list of few companies engaged in the in vivo CRO market.

The report also includes the profiles of key in Adult Vaccines Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  AstraZeneca
•  Bharat Biotech
•  Dynavax Technologies Corporation
•  GlaxoSmithKline
•  Johnson & Johnson
•  Merck and Co
•  Novartis
•  Pfizer
•  Sanofi Pasteur
•  Serum Institute of India

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Adult Vaccines Market Report Scope